Results 11 to 20 of about 26,029 (200)

Pharmacokinetics of teicoplanin in paediatric patients-A systematic review of current literature. [PDF]

open access: yesBr J Clin Pharmacol
Background and Objective Teicoplanin is commonly used in children to treat gram‐positive infections and is sometimes used off‐label prophylactically in surgical or paediatric oncology settings. The pharmacokinetics (PK) of teicoplanin in children exhibit considerable variability, such as in critically ill children or those with renal impairment.
Wijnen NE   +4 more
europepmc   +2 more sources

Immobilised teicoplanin does not demonstrate antimicrobial activity against Staphylococcus aureus

open access: yesScientific Reports, 2022
Antibacterial bone biomaterial coatings appeal to orthopaedics, dentistry and veterinary medicine. Achieving the successful, stable conjugation of suitable compounds to biomaterial surfaces is a major challenge.
S. Britton   +5 more
doaj   +1 more source

Teicoplanin

open access: yesMedical Clinics of North America, 1995
Teicoplanin, a new glycopeptide antibiotic similar to vancomycin, has proved effective in the treatment of various gram-positive infections in both the normal and the immunocompromised host. In vitro activity against most gram-positive organisms is equal to or greater than that of vancomycin.
K W, Shea, B A, Cunha
openaire   +2 more sources

Measurement of teicoplanin by liquid chromatography-tandem mass spectrometry:development of a novel method [PDF]

open access: yes, 2012
Teicoplanin is an antibiotic used for the treatment of endocarditis, osteomyelitis, septic arthritis and methicillin-resistant Staphylococcus aureus. Teicoplanin is emerging as a suitable alternative antibiotic to vancomycin, where their trough serum ...
Bailey, Lisa M   +5 more
core   +1 more source

Drug–drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports

open access: yesScientific Reports, 2023
Teicoplanin can cause acute kidney injury, but little is known about the risk of acute kidney injury when teicoplanin is co-administered with loop diuretics (a powerful diuresis), which can alter renal hemodynamics and glomerular filtration rate.
Toshinori Hirai   +5 more
doaj   +1 more source

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy

open access: yesPharmaceutics, 2022
The dosage regimen of vancomycin, teicoplanin and daptomycin remains controversial for critically ill patients undergoing continuous renal replacement therapy (CRRT).
Jiaojiao Chen   +10 more
doaj   +1 more source

Genome sequencing analysis of Streptomyces coelicolor mutants that overcome the phosphate-depending vancomycin lethal effect [PDF]

open access: yes, 2018
Background Glycopeptide antibiotics inhibit bacterial cell-wall synthesis, and are important for the treatment of infections caused by multi drug-resistant strains of enterococci, streptococci and staphylococci.
Santos Beneit, Fernando
core   +1 more source

Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis [PDF]

open access: yes, 2013
Objectives: To identify risk factors for failure of outpatient antibiotic therapy (OPAT) in infective endocarditis (IE). Patients and methods: We identified IE cases managed at a single centre over 12 years from a prospectively maintained database. ‘
Barr, D. A.   +5 more
core   +1 more source

Quantification of Teicoplanin Using the HPLC-UV Method for Clinical Applications in Critically Ill Patients in Korea

open access: yesPharmaceutics, 2021
A high-performance liquid chromatography-ultraviolet detector (HPLC-UV) method has been used to quantify teicoplanin concentrations in human plasma. However, the limited analytical accuracy of previously bioanalytical methods for teicoplanin has given ...
Jaeok Lee   +4 more
doaj   +1 more source

Nanoparticle‐Based Formulations of Glycopeptide Antibiotics: A Means for Overcoming Vancomycin Resistance in Bacterial Pathogens?

open access: yesAdvanced NanoBiomed Research, 2023
The occurrence and spreading of multidrug resistance in bacterial pathogens represent one of the greatest challenges of the 21st century. With fewer and fewer new antibiotics in development, novel and unconventional concepts in drug development and ...
Bhanu Kiran Pothineni, Adrian Keller
doaj   +1 more source

Home - About - Disclaimer - Privacy